Comparable stake leader
Jacob D. Cohen
SEC ownership of MANGOCEUTICALS, INC.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001938046.
Disclosed value leader
Jacob D. Cohen
Comparable rows
24/27
Latest evidence
31 Mar 2026
- Public ticker
- MGRX on Nasdaq
- Parsed ownership sources
- 13D/G, 3/4/5, and 13F
- Largest SEC-reported holder
- Jacob D. Cohen
- Latest 13D/G holder
- Jacob D. Cohen
- Latest parsed ownership date
- 31 Mar 2026
- Issuer CIK
- 0001938046
- Issuer location
- Dallas, TX
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
2 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of MANGOCEUTICALS, INC. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Jacob D. Cohen
Disclosed value leader
Jacob D. Cohen
Comparable rows
24/27
Latest evidence
31 Mar 2026
13D/G
3/4/5
13F
Lead comparable stake: 15%
3 rows are not safely comparable across share classes.
13D/G row: Jacob D. Cohen
Showing 1-8 of 27 holder rows.
Quick read
Jacob D. Cohen leads the comparable SEC ownership view at 15%.
24 of 27 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Jacob D. Cohen's linked filing trail.
Comparable ownership
Top 5
Jacob D. Cohen
15%
GREENFIELD INVESTMENTS LTD.
14%
Dr. Kenny Myers
0.98%
Lorraine Pamela D'Alessio
0.98%
Eugene M. Johnston
0.86%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 27 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Jacob D. Cohen |
13D/G
3/4/5
Chief Executive Officer, Director, 10%+ Owner
|
15%
|
$4,599,801
2,044,356 shares
|
+$2,526,052 | 21 Jul 2025 |
| GREENFIELD INVESTMENTS LTD. |
13D/G
|
14%
|
$916,700
515,000 shares
|
$0 | 13 Dec 2024 |
| Dr. Kenny Myers |
3/4/5
Director
|
0.98%
|
$232,333
136,667 shares
|
— | 09 Sep 2025 |
| Lorraine Pamela D'Alessio |
3/4/5
Director
|
0.98%
|
$232,333
136,667 shares
|
— | 09 Sep 2025 |
| Eugene M. Johnston |
3/4/5
CFO
|
0.86%
|
$139,836
120,000 shares
|
-$21,139 | 15 Dec 2025 |
| Alex P. Hamilton |
3/4/5
Director
|
0.02%
|
$4,077
3,334 shares
|
-$152,875 | 19 Nov 2025 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
1.4%
|
$70,032
194,482 shares
|
— | 31 Mar 2026 |
| Ikarian Capital, LLC |
13F
Company
|
0.99%
|
$49,747
138,146 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to selling over the last 12 months. Net value: -$174,014.
Buys
$0
Insiders: 0
Sells
$174,014
Insiders: 2
Net
-$174,014
Shares: -143,333
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 143,333
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 8,333 | $0 | $9,859 | -$9,859 |
| 6-9 | 0 | 135,000 | $0 | $164,155 | -$164,155 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-8 of 8 reporting-owner rows connected to MANGOCEUTICALS, INC.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
8
Largest Forms 3/4/5 holder
Jonathan Arango
Net 12M change
-$174,014
Latest report
16 Mar 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Jonathan Arango | President, COO and Secretary, Director | $1,000,000 | Mixed | 20 Mar 2023 | ||
| Jacob D. Cohen | Chief Executive Officer, Director, 10%+ Owner | $260,000 | Mixed | 16 Mar 2026 | ||
| Dr. Kenny Myers | Director | $232,333 | Mixed | 09 Sep 2025 | ||
| Lorraine Pamela D'Alessio | Director | $232,333 | Mixed | 09 Sep 2025 | ||
| Eugene M. Johnston | Cfo | $139,836 | -$21,139 | -13% | Filing P/S | 15 Dec 2025 |
| Amanda Elizabeth Hammer | Chief Operating Officer | $75,000 | Mixed | 03 Jun 2024 | ||
| Alex P. Hamilton | Director | $4,077 | -$152,875 | -97% | Filing P/S | 19 Nov 2025 |
| Antonios Isaac | President, Director | $0 | Mixed | 10 Apr 2025 |
Recent insider transactions for MANGOCEUTICALS, INC.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Jacob D. Cohen | MGRX | Stock Option (right to buy) | Award | 2,133,333 | 2,000,000 | 16 Mar 2026 | Direct | |||
| Jacob D. Cohen | MGRX | Stock Option (right to buy) | Disposed to Issuer | -100% | -2,133,333 | 0 | 16 Mar 2026 | Direct | ||
| Eugene M. Johnston | MGRX | Common Stock | Sale | -2.7% | $3,884 | $1.17 | -3,333 | 120,000 | 15 Dec 2025 | Direct |
| Eugene M. Johnston | MGRX | Common Stock | Sale | -3.9% | $5,975 | $1.20 | -5,000 | 123,333 | 09 Dec 2025 | Direct |
| Eugene M. Johnston | MGRX | Common Stock | Sale | -7.23% | $11,280 | $1.13 | -10,000 | 128,333 | 05 Dec 2025 | Direct |
| Alex P. Hamilton | MGRX | Common Stock | Sale | -97.4% | $152,875 | $1.22 | -125,000 | 3,334 | 19 Nov 2025 | Direct |
| Jacob D. Cohen | MGRX | Common Stock | Award | 500,000 | 500,000 | 09 Sep 2025 | Direct | |||
| Jacob D. Cohen | MGRX | Stock Option (right to buy) | Award | 2,000,000 | 2,000,000 | 09 Sep 2025 | Direct | |||
| Eugene M. Johnston | MGRX | Common Stock | Award | 260.9% | 100,000 | 138,334 | 09 Sep 2025 | Direct | ||
| Lorraine Pamela D'Alessio | MGRX | Common Stock | Award | 272.7% | 100,000 | 136,667 | 09 Sep 2025 | Direct | ||
| Alex P. Hamilton | MGRX | Common Stock | Award | 375% | 100,000 | 126,667 | 09 Sep 2025 | Direct | ||
| Dr. Kenny Myers | MGRX | Common Stock | Award | 272.7% | 100,000 | 136,667 | 09 Sep 2025 | Direct | ||
| Jacob D. Cohen | MGRX | Warrant to Purchase Common Stock | Award | 50,000 | 50,000 | 21 Jul 2025 | Direct | |||
| Jacob D. Cohen | MGRX | Convertible Promissory Note | Award | 0 | $100,000 | 21 Jul 2025 | Direct |
* marks a reported price that did not pass the local price check.